Enter Symbol:

Stock Detail

MARTEK BIOSCIENCES CORPORATION

Biotechnology

MATK @ Yahoo Finance | MATK Option @ Yahoo Finance

Last Day's Data

Current Price High Value Change Percent Change Dividend Previous Close
$31.49 $31.49 $0.00 0.00% 0.00 $31.49
Opening Price Low Volume Market Cap Average Volume P/E
$0.00 $0.00 0 1.06B 1.09M 37.94

Pivot Table

R2 R1 Pivot S1 S2
52.48 41.98 20.99 10.49 -10.50

stock chart

Stock Profile

Martek Biosciences Corporation engages in the development, manufacture, and sale of products derived from microalgae and other microbes primarily in the United States. Its products include nutritional oils used in infant formula, nutritional supplements, and food fortification ingredients, and fluorescent markers for diagnostics and rapid miniaturized screening. The company's nutritional oils consist of fatty acid components, such as docosahexaenoic acid (DHA) and arachidonic acid (ARA). DHA and ARA help in developing the eyes and central nervous systems of newborns, and DHA helps in promoting adult mental and cardiovascular health. It develops fluorescent detection products from microalgae that connect fluorescent algal proteins to antibodies. These products and technologies enable researchers in drug discovery and diagnostics. Fluorescent detection products include Phycobiliproteins, which are classical direct fluorescent detection dyes and SensiLight dyes that are used to match the sensitivity of chemiluminescent methods. Martek Biosciences markets and sells its nutritional oils primarily to the infant formula and natural products industries. The company has a collaborative agreement with SemBioSys Genetics, Inc., a Canadian biotechnology company, to co-develop plant-based DHA products. Martek Biosciences was founded by Radmer in 1985. The company is based in Columbia, Maryland.